Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 109

1.

In vitro and in vivo inhibitory effects of TLR4 agonist, glucopyranosyl lipid A (GLA), on allergic rhinitis caused by Japanese cedar pollen.

Matsumoto K, Kouzaki H, Yamamoto S, Kikuoka H, Tojima I, Ter Meulen JH, Shimizu T.

Allergy. 2020 Feb;75(2):446-449. doi: 10.1111/all.13989. Epub 2019 Oct 24. No abstract available.

PMID:
31318982
2.

First-in-Class, First-in-Human Study Evaluating LV305, a Dendritic-Cell Tropic Lentiviral Vector, in Sarcoma and Other Solid Tumors Expressing NY-ESO-1.

Somaiah N, Block MS, Kim JW, Shapiro GI, Do KT, Hwu P, Eder JP, Jones RL, Lu H, Ter Meulen JH, Bohac C, Chen M, Hsu FJ, Gnjatic S, Pollack SM.

Clin Cancer Res. 2019 Oct 1;25(19):5808-5817. doi: 10.1158/1078-0432.CCR-19-1025. Epub 2019 Jun 21.

PMID:
31227504
3.

First-in-human phase 1 dose-escalating trial of G305 in patients with advanced solid tumors expressing NY-ESO-1.

Mahipal A, Ejadi S, Gnjatic S, Kim-Schulze S, Lu H, Ter Meulen JH, Kenney R, Odunsi K.

Cancer Immunol Immunother. 2019 Jul;68(7):1211-1222. doi: 10.1007/s00262-019-02331-x. Epub 2019 May 8.

PMID:
31069460
4.

Double Lock of a Human Neutralizing and Protective Monoclonal Antibody Targeting the Yellow Fever Virus Envelope.

Lu X, Xiao H, Li S, Pang X, Song J, Liu S, Cheng H, Li Y, Wang X, Huang C, Guo T, Ter Meulen J, Daffis S, Yan J, Dai L, Rao Z, Klenk HD, Qi J, Shi Y, Gao GF.

Cell Rep. 2019 Jan 8;26(2):438-446.e5. doi: 10.1016/j.celrep.2018.12.065.

5.

Intratumoral G100, a TLR4 Agonist, Induces Antitumor Immune Responses and Tumor Regression in Patients with Merkel Cell Carcinoma.

Bhatia S, Miller NJ, Lu H, Longino NV, Ibrani D, Shinohara MM, Byrd DR, Parvathaneni U, Kulikauskas R, Ter Meulen J, Hsu FJ, Koelle DM, Nghiem P.

Clin Cancer Res. 2019 Feb 15;25(4):1185-1195. doi: 10.1158/1078-0432.CCR-18-0469. Epub 2018 Aug 9.

6.

Humoral and cell-mediated immune responses to H5N1 plant-made virus-like particle vaccine are differentially impacted by alum and GLA-SE adjuvants in a Phase 2 clinical trial.

Pillet S, Aubin É, Trépanier S, Poulin JF, Yassine-Diab B, Ter Meulen J, Ward BJ, Landry N.

NPJ Vaccines. 2018 Jan 23;3:3. doi: 10.1038/s41541-017-0043-3. eCollection 2018.

7.

First-in-Human Treatment With a Dendritic Cell-targeting Lentiviral Vector-expressing NY-ESO-1, LV305, Induces Deep, Durable Response in Refractory Metastatic Synovial Sarcoma Patient.

Pollack SM, Lu H, Gnjatic S, Somaiah N, O'Malley RB, Jones RL, Hsu FJ, Ter Meulen J.

J Immunother. 2017 Oct;40(8):302-306. doi: 10.1097/CJI.0000000000000183.

8.

HIV-1 Conserved Mosaics Delivered by Regimens with Integration-Deficient DC-Targeting Lentiviral Vector Induce Robust T Cells.

Wee EG, Ondondo B, Berglund P, Archer J, McMichael AJ, Baltimore D, Ter Meulen JH, Hanke T.

Mol Ther. 2017 Feb 1;25(2):494-503. doi: 10.1016/j.ymthe.2016.12.004.

9.

Immune Design.

Ter Meulen J, Brady SR.

Hum Vaccin Immunother. 2017 Jan 2;13(1):15-16. doi: 10.1080/21645515.2016.1239490. Epub 2016 Nov 21. No abstract available.

10.

LV305, a dendritic cell-targeting integration-deficient ZVex(TM)-based lentiviral vector encoding NY-ESO-1, induces potent anti-tumor immune response.

Albershardt TC, Campbell DJ, Parsons AJ, Slough MM, Ter Meulen J, Berglund P.

Mol Ther Oncolytics. 2016 Mar 30;3:16010. doi: 10.1038/mto.2016.10. eCollection 2016.

11.

An Inactivated Rabies Virus-Based Ebola Vaccine, FILORAB1, Adjuvanted With Glucopyranosyl Lipid A in Stable Emulsion Confers Complete Protection in Nonhuman Primate Challenge Models.

Johnson RF, Kurup D, Hagen KR, Fisher C, Keshwara R, Papaneri A, Perry DL, Cooper K, Jahrling PB, Wang JT, Ter Meulen J, Wirblich C, Schnell MJ.

J Infect Dis. 2016 Oct 15;214(suppl 3):S342-S354. Epub 2016 Jul 24.

12.

A Rapid and Improved Method to Generate Recombinant Dengue Virus Vaccine Candidates.

Govindarajan D, Guan L, Meschino S, Fridman A, Bagchi A, Pak I, ter Meulen J, Casimiro DR, Bett AJ.

PLoS One. 2016 Mar 23;11(3):e0152209. doi: 10.1371/journal.pone.0152209. eCollection 2016.

13.

Arenavirus Glycan Shield Promotes Neutralizing Antibody Evasion and Protracted Infection.

Sommerstein R, Flatz L, Remy MM, Malinge P, Magistrelli G, Fischer N, Sahin M, Bergthaler A, Igonet S, Ter Meulen J, Rigo D, Meda P, Rabah N, Coutard B, Bowden TA, Lambert PH, Siegrist CA, Pinschewer DD.

PLoS Pathog. 2015 Nov 20;11(11):e1005276. doi: 10.1371/journal.ppat.1005276. eCollection 2015 Nov.

14.

A novel HSV-2 subunit vaccine induces GLA-dependent CD4 and CD8 T cell responses and protective immunity in mice and guinea pigs.

Odegard JM, Flynn PA, Campbell DJ, Robbins SH, Dong L, Wang K, Ter Meulen J, Cohen JI, Koelle DM.

Vaccine. 2016 Jan 2;34(1):101-9. doi: 10.1016/j.vaccine.2015.10.137. Epub 2015 Nov 10.

15.

Preclinical development of a dengue tetravalent recombinant subunit vaccine: Immunogenicity and protective efficacy in nonhuman primates.

Govindarajan D, Meschino S, Guan L, Clements DE, ter Meulen JH, Casimiro DR, Coller BA, Bett AJ.

Vaccine. 2015 Aug 7;33(33):4105-16. doi: 10.1016/j.vaccine.2015.06.067. Epub 2015 Jul 3.

PMID:
26144900
16.

Virological and preclinical characterization of a dendritic cell targeting, integration-deficient lentiviral vector for cancer immunotherapy.

Odegard JM, Kelley-Clarke B, Tareen SU, Campbell DJ, Flynn PA, Nicolai CJ, Slough MM, Vin CD, McGowan PJ, Nelson LT, Ter Meulen J, Dubensky TW Jr, Robbins SH.

J Immunother. 2015 Feb-Mar;38(2):41-53. doi: 10.1097/CJI.0000000000000067.

17.

Differential and integral cross sections in OH(X) + Xe collisions.

Sarma G, Saha AK, ter Meulen JJ, Parker DH, Marinakis S.

J Chem Phys. 2015 Jan 21;142(3):034309. doi: 10.1063/1.4906070.

PMID:
25612711
18.

Priorities for research on tropical viruses after the 2014 Ebola epidemic.

ter Meulen J.

J Clin Virol. 2015 Mar;64:107-8. doi: 10.1016/j.jcv.2014.12.008. Epub 2014 Dec 12. No abstract available.

PMID:
25572776
19.

Research efforts to control highly pathogenic arenaviruses: a summary of the progress and gaps.

Kerber R, Reindl S, Romanowski V, Gómez RM, Ogbaini-Emovon E, Günther S, ter Meulen J.

J Clin Virol. 2015 Mar;64:120-7. doi: 10.1016/j.jcv.2014.12.004. Epub 2014 Dec 18. Review.

PMID:
25549822
20.

Abortive intrabronchial infection of rhesus macaques with varicella-zoster virus provides partial protection against simian varicella virus challenge.

Meyer C, Engelmann F, Arnold N, Krah DL, ter Meulen J, Haberthur K, Dewane J, Messaoudi I.

J Virol. 2015 Feb;89(3):1781-93. doi: 10.1128/JVI.03124-14. Epub 2014 Nov 19.

21.

RCWA and FDTD modeling of light emission from internally structured OLEDs.

Callens MK, Marsman H, Penninck L, Peeters P, de Groot H, ter Meulen JM, Neyts K.

Opt Express. 2014 May 5;22 Suppl 3:A589-600. doi: 10.1364/OE.22.00A589.

PMID:
24922367
22.

Immunogenicity of a reduced-dose whole killed rabies vaccine is significantly enhanced by ISCOMATRIX™ adjuvant, Merck amorphous aluminum hydroxylphosphate sulfate (MAA) or a synthetic TLR9 agonist in rhesus macaques.

DiStefano D, Antonello JM, Bett AJ, Medi MB, Casimiro DR, ter Meulen J.

Vaccine. 2013 Oct 1;31(42):4888-93. doi: 10.1016/j.vaccine.2013.07.034. Epub 2013 Aug 11.

PMID:
23941913
23.

Caspase activation as a versatile assay platform for detection of cytotoxic bacterial toxins.

Payne AM, Zorman J, Horton M, Dubey S, ter Meulen J, Vora KA.

J Clin Microbiol. 2013 Sep;51(9):2970-6. doi: 10.1128/JCM.01161-13. Epub 2013 Jul 3.

24.

Sporozoite neutralizing antibodies elicited in mice and rhesus macaques immunized with a Plasmodium falciparum repeat peptide conjugated to meningococcal outer membrane protein complex.

Przysiecki C, Lucas B, Mitchell R, Carapau D, Wen Z, Xu H, Wang XM, Nahas D, Wu C, Hepler R, Ottinger E, Ter Meulen J, Kaslow D, Shiver J, Nardin E.

Front Cell Infect Microbiol. 2012 Nov 30;2:146. doi: 10.3389/fcimb.2012.00146. eCollection 2012.

25.

Inelastic scattering of hydroxyl radicals with helium and argon by velocity-map imaging.

Sarma G, Marinakis S, ter Meulen JJ, Parker DH, McKendrick KG.

Nat Chem. 2012 Dec;4(12):985-9. doi: 10.1038/nchem.1480. Epub 2012 Oct 28.

PMID:
23174977
26.

Restoration of viral epithelial tropism improves immunogenicity in rabbits and rhesus macaques for a whole virion vaccine of human cytomegalovirus.

Fu TM, Wang D, Freed DC, Tang A, Li F, He X, Cole S, Dubey S, Finnefrock AC, ter Meulen J, Shiver JW, Casimiro DR.

Vaccine. 2012 Dec 14;30(52):7469-74. doi: 10.1016/j.vaccine.2012.10.053. Epub 2012 Oct 26.

PMID:
23107592
27.

Design of Escherichia coli-expressed stalk domain immunogens of H1N1 hemagglutinin that protect mice from lethal challenge.

Bommakanti G, Lu X, Citron MP, Najar TA, Heidecker GJ, ter Meulen J, Varadarajan R, Liang X.

J Virol. 2012 Dec;86(24):13434-44. doi: 10.1128/JVI.01429-12. Epub 2012 Sep 26.

28.

The impact of human conflict on the genetics of Mastomys natalensis and Lassa virus in West Africa.

Lalis A, Leblois R, Lecompte E, Denys C, Ter Meulen J, Wirth T.

PLoS One. 2012;7(5):e37068. doi: 10.1371/journal.pone.0037068. Epub 2012 May 15.

29.

Sangassou virus, the first hantavirus isolate from Africa, displays genetic and functional properties distinct from those of other murinae-associated hantaviruses.

Klempa B, Witkowski PT, Popugaeva E, Auste B, Koivogui L, Fichet-Calvet E, Strecker T, Ter Meulen J, Krüger DH.

J Virol. 2012 Apr;86(7):3819-27. doi: 10.1128/JVI.05879-11. Epub 2012 Jan 25.

30.

Transcriptional profiling of vaccine-induced immune responses in humans and non-human primates.

Wang IM, Bett AJ, Cristescu R, Loboda A, ter Meulen J.

Microb Biotechnol. 2012 Mar;5(2):177-87. doi: 10.1111/j.1751-7915.2011.00317.x. Epub 2011 Nov 22. Review.

31.

Monoclonal antibodies in infectious diseases: clinical pipeline in 2011.

Ter Meulen J.

Infect Dis Clin North Am. 2011 Dec;25(4):789-802. doi: 10.1016/j.idc.2011.07.006. Review.

PMID:
22054756
32.

Management of accidental exposure to Ebola virus in the biosafety level 4 laboratory, Hamburg, Germany.

Günther S, Feldmann H, Geisbert TW, Hensley LE, Rollin PE, Nichol ST, Ströher U, Artsob H, Peters CJ, Ksiazek TG, Becker S, ter Meulen J, Olschläger S, Schmidt-Chanasit J, Sudeck H, Burchard GD, Schmiedel S.

J Infect Dis. 2011 Nov;204 Suppl 3:S785-90. doi: 10.1093/infdis/jir298.

PMID:
21987751
33.

The development of recombinant subunit envelope-based vaccines to protect against dengue virus induced disease.

Coller BA, Clements DE, Bett AJ, Sagar SL, Ter Meulen JH.

Vaccine. 2011 Sep 23;29(42):7267-75. doi: 10.1016/j.vaccine.2011.07.021. Epub 2011 Jul 21. Review.

34.

Mandibular overdentures supported by 6-mm dental implants: a 1-year prospective cohort study.

Guljé F, Raghoebar GM, Ter Meulen JW, Vissink A, Meijer HJ.

Clin Implant Dent Relat Res. 2012 May;14 Suppl 1:e59-66. doi: 10.1111/j.1708-8208.2011.00358.x. Epub 2011 Jul 11.

PMID:
21745319
35.

Novel arenavirus sequences in Hylomyscus sp. and Mus (Nannomys) setulosus from Côte d'Ivoire: implications for evolution of arenaviruses in Africa.

Coulibaly-N'Golo D, Allali B, Kouassi SK, Fichet-Calvet E, Becker-Ziaja B, Rieger T, Olschläger S, Dosso H, Denys C, Ter Meulen J, Akoua-Koffi C, Günther S.

PLoS One. 2011;6(6):e20893. doi: 10.1371/journal.pone.0020893. Epub 2011 Jun 9.

36.

State-to-state differential and relative integral cross sections for rotationally inelastic scattering of H2O by hydrogen.

Yang CH, Sarma G, Parker DH, ter Meulen JJ, Wiesenfeld L.

J Chem Phys. 2011 May 28;134(20):204308. doi: 10.1063/1.3589360.

PMID:
21639441
37.

Current molecular epidemiology of Lassa virus in Nigeria.

Ehichioya DU, Hass M, Becker-Ziaja B, Ehimuan J, Asogun DA, Fichet-Calvet E, Kleinsteuber K, Lelke M, ter Meulen J, Akpede GO, Omilabu SA, Günther S, Olschläger S.

J Clin Microbiol. 2011 Mar;49(3):1157-61. doi: 10.1128/JCM.01891-10. Epub 2010 Dec 29.

38.

Communication: Mapping water collisions for interstellar space conditions.

Yang CH, Sarma G, ter Meulen JJ, Parker DH, McBane GC, Wiesenfeld L, Faure A, Scribano Y, Feautrier N.

J Chem Phys. 2010 Oct 7;133(13):131103. doi: 10.1063/1.3475517.

PMID:
20942516
39.

REMPI spectroscopy and predissociation of the C(1)B(1)(v = 0) rotational levels of H(2)O, HOD and D(2)O.

Yang CH, Sarma G, Ter Meulen JJ, Parker DH, Western CM.

Phys Chem Chem Phys. 2010 Nov 14;12(42):13983-91. doi: 10.1039/c0cp00946f. Epub 2010 Sep 22.

PMID:
20859586
40.

Pushing the envelope on HIV-1 neutralization.

Joyce JG, ter Meulen J.

Nat Biotechnol. 2010 Sep;28(9):929-31. doi: 10.1038/nbt0910-929. No abstract available.

PMID:
20829830
41.

Imaging the inelastic scattering of water with helium. Comparison of experiment and theory.

Yang CH, Sarma G, Ter Meulen JJ, Parker DH, Buck U, Wiesenfeld L.

J Phys Chem A. 2010 Sep 16;114(36):9886-92. doi: 10.1021/jp1035713.

PMID:
20825242
42.

Design of an HA2-based Escherichia coli expressed influenza immunogen that protects mice from pathogenic challenge.

Bommakanti G, Citron MP, Hepler RW, Callahan C, Heidecker GJ, Najar TA, Lu X, Joyce JG, Shiver JW, Casimiro DR, ter Meulen J, Liang X, Varadarajan R.

Proc Natl Acad Sci U S A. 2010 Aug 3;107(31):13701-6. doi: 10.1073/pnas.1007465107. Epub 2010 Jul 6.

43.

Molybdenum interlayers for nucleation enhancement in diamond CVD growth.

Buijnsters JG, Vázquez L, Galindo RE, ter Meulen JJ.

J Nanosci Nanotechnol. 2010 Apr;10(4):2885-91.

PMID:
20355518
44.

Serological evidence of human hantavirus infections in Guinea, West Africa.

Klempa B, Koivogui L, Sylla O, Koulemou K, Auste B, Krüger DH, ter Meulen J.

J Infect Dis. 2010 Apr 1;201(7):1031-4. doi: 10.1086/651169.

PMID:
20187741
45.

Predissociation of the A2Sigma+ (v' = 3) state of the OH radical.

Radenović DC, van Roij AJ, Wu SM, Ter Meulen JJ, Parker DH, van der Loo MP, Groenenboom GC.

Phys Chem Chem Phys. 2009 Jun 21;11(23):4754-60. doi: 10.1039/b900249a. Epub 2009 Apr 7.

PMID:
19492129
46.

Characterization of Lassa virus cell entry and neutralization with Lassa virus pseudoparticles.

Cosset FL, Marianneau P, Verney G, Gallais F, Tordo N, Pécheur EI, ter Meulen J, Deubel V, Bartosch B.

J Virol. 2009 Apr;83(7):3228-37. doi: 10.1128/JVI.01711-08. Epub 2009 Jan 19.

47.

Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells.

Throsby M, van den Brink E, Jongeneelen M, Poon LL, Alard P, Cornelissen L, Bakker A, Cox F, van Deventer E, Guan Y, Cinatl J, ter Meulen J, Lasters I, Carsetti R, Peiris M, de Kruif J, Goudsmit J.

PLoS One. 2008;3(12):e3942. doi: 10.1371/journal.pone.0003942. Epub 2008 Dec 16.

48.

Laser-induced fluorescence of NCN in low and atmospheric pressure flames.

Klein-Douwel RJ, Dam NJ, ter Meulen JJ.

Opt Lett. 2008 Nov 15;33(22):2620-2.

PMID:
19015687
49.

Methods to correct planar laser-induced fluorescence distributions for local nonuniform laser attenuation.

Stoffels GG, Stoks S, Dam N, ter Meulen JJ.

Appl Opt. 2000 Oct 20;39(30):5547-59.

PMID:
18354552
50.

Generation of 224-nm radiation by stimulated Raman scattering of ArF excimer laser radiation in a mixture of H2 and D2.

Stoffels GG, Schmidt P, Dam N, ter Meulen JJ.

Appl Opt. 1997 Sep 20;36(27):6797-801.

PMID:
18259547

Supplemental Content

Loading ...
Support Center